Why EOP1 Matters When Phase 1 Data Are Foreign For many global drug and biologic developers, the first human data package is no longer generated entirely in the United States. Sponsors may complete Phase 1 studies in Asia, Europe, Australia, or other regions, then seek US FDA agreement before moving into U.S. Phase 2 development, [...]